Global Antineoplastic Drugs Market Professional Survey Report 2018

March 2018 | 116 pages | ID: GFDDE370F68EN
QYResearch

Abstracts

This report studies Antineoplastic Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Hoffmann-La Roche
• Amgen
• Bristol-Myers Squibb
• Baxter Healthcare
• Boehringer Ingelheim
• Aspen Global
• Bayer AG
• Teva pharmaceutical Industries
• Johnson & Johnson
• Merc & Co.
• Pfize
• Accord Healthcare
• Genentech
• Lundbeck
• AbbVie

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Chemotherapeutic Agents
• Biological/Immunotherapeutic Agents
• Personalized Medicine

By Application, the market can be split into

• Hospitals
• Clinics
• Cancer Rehabilitation Centers
• Ambulatory Surgical Centers

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Antineoplastic Drugs Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF ANTINEOPLASTIC DRUGS

1.1 Definition and Specifications of Antineoplastic Drugs
  1.1.1 Definition of Antineoplastic Drugs
  1.1.2 Specifications of Antineoplastic Drugs
1.2 Classification of Antineoplastic Drugs
  1.2.1 Chemotherapeutic Agents
  1.2.2 Biological/Immunotherapeutic Agents
  1.2.3 Personalized Medicine
1.3 Applications of Antineoplastic Drugs
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Cancer Rehabilitation Centers
  1.3.4 Ambulatory Surgical Centers
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTINEOPLASTIC DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antineoplastic Drugs
2.3 Manufacturing Process Analysis of Antineoplastic Drugs
2.4 Industry Chain Structure of Antineoplastic Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTINEOPLASTIC DRUGS

3.1 Capacity and Commercial Production Date of Global Antineoplastic Drugs Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Antineoplastic Drugs Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Antineoplastic Drugs Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Antineoplastic Drugs Major Manufacturers in 2017

4 GLOBAL ANTINEOPLASTIC DRUGS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Antineoplastic Drugs Capacity and Growth Rate Analysis
  4.2.2 2017 Antineoplastic Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Antineoplastic Drugs Sales and Growth Rate Analysis
  4.3.2 2017 Antineoplastic Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Antineoplastic Drugs Sales Price
  4.4.2 2017 Antineoplastic Drugs Sales Price Analysis (Company Segment)

5 ANTINEOPLASTIC DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Antineoplastic Drugs Market Analysis
  5.1.1 North America Antineoplastic Drugs Market Overview
  5.1.2 North America 2013-2018E Antineoplastic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Antineoplastic Drugs Sales Price Analysis
  5.1.4 North America 2017 Antineoplastic Drugs Market Share Analysis
5.2 China Antineoplastic Drugs Market Analysis
  5.2.1 China Antineoplastic Drugs Market Overview
  5.2.2 China 2013-2018E Antineoplastic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Antineoplastic Drugs Sales Price Analysis
  5.2.4 China 2017 Antineoplastic Drugs Market Share Analysis
5.3 Europe Antineoplastic Drugs Market Analysis
  5.3.1 Europe Antineoplastic Drugs Market Overview
  5.3.2 Europe 2013-2018E Antineoplastic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Antineoplastic Drugs Sales Price Analysis
  5.3.4 Europe 2017 Antineoplastic Drugs Market Share Analysis
5.4 Southeast Asia Antineoplastic Drugs Market Analysis
  5.4.1 Southeast Asia Antineoplastic Drugs Market Overview
  5.4.2 Southeast Asia 2013-2018E Antineoplastic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Antineoplastic Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2017 Antineoplastic Drugs Market Share Analysis
5.5 Japan Antineoplastic Drugs Market Analysis
  5.5.1 Japan Antineoplastic Drugs Market Overview
  5.5.2 Japan 2013-2018E Antineoplastic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Antineoplastic Drugs Sales Price Analysis
  5.5.4 Japan 2017 Antineoplastic Drugs Market Share Analysis
5.6 India Antineoplastic Drugs Market Analysis
  5.6.1 India Antineoplastic Drugs Market Overview
  5.6.2 India 2013-2018E Antineoplastic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Antineoplastic Drugs Sales Price Analysis
  5.6.4 India 2017 Antineoplastic Drugs Market Share Analysis

6 GLOBAL 2013-2018E ANTINEOPLASTIC DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Antineoplastic Drugs Sales by Type
6.2 Different Types of Antineoplastic Drugs Product Interview Price Analysis
6.3 Different Types of Antineoplastic Drugs Product Driving Factors Analysis
  6.3.1 Chemotherapeutic Agents of Antineoplastic Drugs Growth Driving Factor Analysis
  6.3.2 Biological/Immunotherapeutic Agents of Antineoplastic Drugs Growth Driving Factor Analysis
  6.3.3 Personalized Medicine of Antineoplastic Drugs Growth Driving Factor Analysis

7 GLOBAL 2013-2018E ANTINEOPLASTIC DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Antineoplastic Drugs Consumption by Application
7.2 Different Application of Antineoplastic Drugs Product Interview Price Analysis
7.3 Different Application of Antineoplastic Drugs Product Driving Factors Analysis
  7.3.1 Hospitals of Antineoplastic Drugs Growth Driving Factor Analysis
  7.3.2 Clinics of Antineoplastic Drugs Growth Driving Factor Analysis
  7.3.3 Cancer Rehabilitation Centers of Antineoplastic Drugs Growth Driving Factor Analysis
  7.3.4 Ambulatory Surgical Centers of Antineoplastic Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTINEOPLASTIC DRUGS

8.1 Hoffmann-La Roche
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Hoffmann-La Roche 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Hoffmann-La Roche 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.2 Amgen
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Amgen 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Amgen 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.3 Bristol-Myers Squibb
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Bristol-Myers Squibb 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Bristol-Myers Squibb 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.4 Baxter Healthcare
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Baxter Healthcare 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Baxter Healthcare 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.5 Boehringer Ingelheim
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Boehringer Ingelheim 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Boehringer Ingelheim 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.6 Aspen Global
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Aspen Global 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Aspen Global 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.7 Bayer AG
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Bayer AG 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Bayer AG 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.8 Teva pharmaceutical Industries
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Teva pharmaceutical Industries 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Teva pharmaceutical Industries 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.9 Johnson & Johnson
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Johnson & Johnson 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Johnson & Johnson 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.10 Merc & Co.
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Merc & Co. 2017 Antineoplastic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Merc & Co. 2017 Antineoplastic Drugs Business Region Distribution Analysis
8.11 Pfize
8.12 Accord Healthcare
8.13 Genentech
8.14 Lundbeck
8.15 AbbVie

9 DEVELOPMENT TREND OF ANALYSIS OF ANTINEOPLASTIC DRUGS MARKET

9.1 Global Antineoplastic Drugs Market Trend Analysis
  9.1.1 Global 2018-2025 Antineoplastic Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Antineoplastic Drugs Sales Price Forecast
9.2 Antineoplastic Drugs Regional Market Trend
  9.2.1 North America 2018-2025 Antineoplastic Drugs Consumption Forecast
  9.2.2 China 2018-2025 Antineoplastic Drugs Consumption Forecast
  9.2.3 Europe 2018-2025 Antineoplastic Drugs Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Antineoplastic Drugs Consumption Forecast
  9.2.5 Japan 2018-2025 Antineoplastic Drugs Consumption Forecast
  9.2.6 India 2018-2025 Antineoplastic Drugs Consumption Forecast
9.3 Antineoplastic Drugs Market Trend (Product Type)
9.4 Antineoplastic Drugs Market Trend (Application)

10 ANTINEOPLASTIC DRUGS MARKETING TYPE ANALYSIS

10.1 Antineoplastic Drugs Regional Marketing Type Analysis
10.2 Antineoplastic Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antineoplastic Drugs by Region
10.4 Antineoplastic Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTINEOPLASTIC DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ANTINEOPLASTIC DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antineoplastic Drugs
Table Product Specifications of Antineoplastic Drugs
Table Classification of Antineoplastic Drugs
Figure Global Production Market Share of Antineoplastic Drugs by Type in 2017
Figure Chemotherapeutic Agents Picture
Table Major Manufacturers of Chemotherapeutic Agents
Figure Biological/Immunotherapeutic Agents Picture
Table Major Manufacturers of Biological/Immunotherapeutic Agents
Figure Personalized Medicine Picture
Table Major Manufacturers of Personalized Medicine
Table Applications of Antineoplastic Drugs
Figure Global Consumption Volume Market Share of Antineoplastic Drugs by Application in 2017
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Cancer Rehabilitation Centers Examples
Table Major Consumers in Cancer Rehabilitation Centers
Figure Ambulatory Surgical Centers Examples
Table Major Consumers in Ambulatory Surgical Centers
Figure Market Share of Antineoplastic Drugs by Regions
Figure North America Antineoplastic Drugs Market Size (Million USD) (2013-2025)
Figure China Antineoplastic Drugs Market Size (Million USD) (2013-2025)
Figure Europe Antineoplastic Drugs Market Size (Million USD) (2013-2025)
Figure Southeast Asia Antineoplastic Drugs Market Size (Million USD) (2013-2025)
Figure Japan Antineoplastic Drugs Market Size (Million USD) (2013-2025)
Figure India Antineoplastic Drugs Market Size (Million USD) (2013-2025)
Table Antineoplastic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antineoplastic Drugs in 2017
Figure Manufacturing Process Analysis of Antineoplastic Drugs
Figure Industry Chain Structure of Antineoplastic Drugs
Table Capacity and Commercial Production Date of Global Antineoplastic Drugs Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Antineoplastic Drugs Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Antineoplastic Drugs Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Antineoplastic Drugs Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Antineoplastic Drugs 2013-2018E
Figure Global 2013-2018E Antineoplastic Drugs Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Antineoplastic Drugs Market Size (Value) and Growth Rate
Table 2013-2018E Global Antineoplastic Drugs Capacity and Growth Rate
Table 2017 Global Antineoplastic Drugs Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Antineoplastic Drugs Sales (K Units) and Growth Rate
Table 2017 Global Antineoplastic Drugs Sales (K Units) List (Company Segment)
Table 2013-2018E Global Antineoplastic Drugs Sales Price (USD/Unit)
Table 2017 Global Antineoplastic Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Antineoplastic Drugs 2013-2018E
Figure North America 2013-2018E Antineoplastic Drugs Sales Price (USD/Unit)
Figure North America 2017 Antineoplastic Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Antineoplastic Drugs 2013-2018E
Figure China 2013-2018E Antineoplastic Drugs Sales Price (USD/Unit)
Figure China 2017 Antineoplastic Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Antineoplastic Drugs 2013-2018E
Figure Europe 2013-2018E Antineoplastic Drugs Sales Price (USD/Unit)
Figure Europe 2017 Antineoplastic Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Antineoplastic Drugs 2013-2018E
Figure Southeast Asia 2013-2018E Antineoplastic Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2017 Antineoplastic Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Antineoplastic Drugs 2013-2018E
Figure Japan 2013-2018E Antineoplastic Drugs Sales Price (USD/Unit)
Figure Japan 2017 Antineoplastic Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Antineoplastic Drugs 2013-2018E
Figure India 2013-2018E Antineoplastic Drugs Sales Price (USD/Unit)
Figure India 2017 Antineoplastic Drugs Sales Market Share
Table Global 2013-2018E Antineoplastic Drugs Sales (K Units) by Type
Table Different Types Antineoplastic Drugs Product Interview Price
Table Global 2013-2018E Antineoplastic Drugs Sales (K Units) by Application
Table Different Application Antineoplastic Drugs Product Interview Price
Table Hoffmann-La Roche Information List
Table Product A Overview
Table Product B Overview
Table 2017 Hoffmann-La Roche Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Hoffmann-La Roche Antineoplastic Drugs Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2017 Amgen Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Amgen Antineoplastic Drugs Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2015 Bristol-Myers Squibb Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bristol-Myers Squibb Antineoplastic Drugs Business Region Distribution
Table Baxter Healthcare Information List
Table Product A Overview
Table Product B Overview
Table 2017 Baxter Healthcare Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Baxter Healthcare Antineoplastic Drugs Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2017 Boehringer Ingelheim Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Boehringer Ingelheim Antineoplastic Drugs Business Region Distribution
Table Aspen Global Information List
Table Product A Overview
Table Product B Overview
Table 2017 Aspen Global Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Aspen Global Antineoplastic Drugs Business Region Distribution
Table Bayer AG Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bayer AG Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer AG Antineoplastic Drugs Business Region Distribution
Table Teva pharmaceutical Industries Information List
Table Product A Overview
Table Product B Overview
Table 2017 Teva pharmaceutical Industries Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Teva pharmaceutical Industries Antineoplastic Drugs Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2017 Johnson & Johnson Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Johnson & Johnson Antineoplastic Drugs Business Region Distribution
Table Merc & Co. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Merc & Co. Antineoplastic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Merc & Co. Antineoplastic Drugs Business Region Distribution
Table Pfize Information List
Table Accord Healthcare Information List
Table Genentech Information List
Table Lundbeck Information List
Table AbbVie Information List
Figure Global 2018-2025 Antineoplastic Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Antineoplastic Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Antineoplastic Drugs Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Antineoplastic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Antineoplastic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Antineoplastic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Antineoplastic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Antineoplastic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Antineoplastic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Antineoplastic Drugs by Type 2018-2025
Table Global Consumption Volume (K Units) of Antineoplastic Drugs by Application 2018-2025
Table Traders or Distributors with Contact Information of Antineoplastic Drugs by Region